Tuberculosis and other mycobacterial diseases. In: FreedbergI.M., eds. Fitzpatrick's Dermatology in General Medicine.5th ed.New York, NY: McGraw-Hill; 1999: 2291–2292.
6.
WallaceR.J.Jr, BrownB.A., OnyiG.O.Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis.1992; 166: 405–412.
ScullyR.E., MarkE.J., McNeelyW.F.Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-1997: a 74-year-old man with progressive cough, dyspnea, and pleural thickening. N Engl J Med.1996; 335: 1303–1307.
9.
WoodsG.L., WashingtonJ.A.II. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis.1987; 9: 275–294.
10.
WallaceR.J.Jr, SwensonJ.M., SilcoxV.A.Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis.1983; 5: 657–679.
11.
PruittT.C., HughesL.O., BlasierR.D.Atypical mycobacterial vertebral osteomyelitis in a steroid-dependent adolescent: a case report. Spine.1993; 18: 2553–2555.
12.
WilsonS., AscioB., NeitzschmanH.R.Radiology case of the month. Nail puncture wound to the foot: Mycobacterium chelonei osteomyelitis. J La State Med Soc.1999; 151: 251–252.
13.
HsuehP.R., TengL.J., YangP.C.Recurrent catheter-related infection caused by a single clone of Mycobacterium chelonae with two colonial morphotypes. J Clin Microbiol.1998; 36: 1422–1424.
14.
EichmannA., HuszarA., BonA.Mycobacterium chelonae infection of lymph nodes in an HIV-infected patient. Dermatology.1993; 187: 299–300.
15.
GreerK.E., GrossG.P., MartensenS.H.Sporotrichoid cutaneous infection due to Mycobacterium chelonei.Arch Dermatol.1979; 115: 738–739.
16.
ZahidM.A., KlotzS.A., GoldsteinE.Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin Infect Dis.1994; 18: 999–1001.
17.
WallaceR.J.Jr, TannerD., BrennanP.J.Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.Ann Intern Med.1993; 119: 482–486.
18.
SalujaA., PetersN.T., LoweL.A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol Surg.1997; 23: 539–543.
19.
FranckN., CabieA., VilletteB.Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol.1993; 28: 1019–1021.
20.
DriscollM.S., TyringS.K.Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol.1997; 36(3 Pt 1): 495–496.
21.
TebasP., SultanF., WallaceR.J.Jr. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin Infect Dis.1995; 20: 443–444.
22.
IsemanM.D.Group IV: Rapid growing mycobacteria. In: YuV.L., MeriganT.C.Jr, BarriereS.L., eds. Antimicrobial Therapy and Vaccines.Baltimore, Md: William & Wilkins; 1999: 494–497.
23.
Fridolijn JongevosS., PrensE.P., HabetsJ.M.Successful triple-antibiotic therapy for cutaneous infection due to Mycobacterium chelonae. Clin Infect Dis.1999; 28: 145–146.
24.
ColskyA.S., HanlyA., ElgartG.Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy. Arch Dermatol.1999; 135: 125–127.
25.
NewportM.J., HuxleyC.M., HustonS.A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med.1996; 335: 1941–1949.